S&P 500   3,761.88 (-0.17%)
DOW   30,954.06 (+0.10%)
QQQ   300.41 (-1.21%)
AAPL   118.15 (-1.65%)
MSFT   228.22 (+0.66%)
FB   257.53 (-0.04%)
GOOGL   2,047.68 (+0.68%)
TSLA   565.00 (-9.08%)
AMZN   2,918.01 (-2.00%)
NVDA   475.85 (-3.83%)
BABA   229.55 (-0.41%)
CGC   29.02 (-6.42%)
GE   13.36 (-1.55%)
MU   85.17 (+1.00%)
NIO   32.23 (-17.95%)
AMD   75.67 (-2.68%)
T   29.39 (+1.63%)
F   11.82 (-0.92%)
ACB   8.98 (-8.55%)
DIS   185.35 (-1.43%)
BA   216.76 (-3.54%)
NFLX   505.39 (-1.15%)
BAC   36.34 (-0.44%)
S&P 500   3,761.88 (-0.17%)
DOW   30,954.06 (+0.10%)
QQQ   300.41 (-1.21%)
AAPL   118.15 (-1.65%)
MSFT   228.22 (+0.66%)
FB   257.53 (-0.04%)
GOOGL   2,047.68 (+0.68%)
TSLA   565.00 (-9.08%)
AMZN   2,918.01 (-2.00%)
NVDA   475.85 (-3.83%)
BABA   229.55 (-0.41%)
CGC   29.02 (-6.42%)
GE   13.36 (-1.55%)
MU   85.17 (+1.00%)
NIO   32.23 (-17.95%)
AMD   75.67 (-2.68%)
T   29.39 (+1.63%)
F   11.82 (-0.92%)
ACB   8.98 (-8.55%)
DIS   185.35 (-1.43%)
BA   216.76 (-3.54%)
NFLX   505.39 (-1.15%)
BAC   36.34 (-0.44%)
S&P 500   3,761.88 (-0.17%)
DOW   30,954.06 (+0.10%)
QQQ   300.41 (-1.21%)
AAPL   118.15 (-1.65%)
MSFT   228.22 (+0.66%)
FB   257.53 (-0.04%)
GOOGL   2,047.68 (+0.68%)
TSLA   565.00 (-9.08%)
AMZN   2,918.01 (-2.00%)
NVDA   475.85 (-3.83%)
BABA   229.55 (-0.41%)
CGC   29.02 (-6.42%)
GE   13.36 (-1.55%)
MU   85.17 (+1.00%)
NIO   32.23 (-17.95%)
AMD   75.67 (-2.68%)
T   29.39 (+1.63%)
F   11.82 (-0.92%)
ACB   8.98 (-8.55%)
DIS   185.35 (-1.43%)
BA   216.76 (-3.54%)
NFLX   505.39 (-1.15%)
BAC   36.34 (-0.44%)
S&P 500   3,761.88 (-0.17%)
DOW   30,954.06 (+0.10%)
QQQ   300.41 (-1.21%)
AAPL   118.15 (-1.65%)
MSFT   228.22 (+0.66%)
FB   257.53 (-0.04%)
GOOGL   2,047.68 (+0.68%)
TSLA   565.00 (-9.08%)
AMZN   2,918.01 (-2.00%)
NVDA   475.85 (-3.83%)
BABA   229.55 (-0.41%)
CGC   29.02 (-6.42%)
GE   13.36 (-1.55%)
MU   85.17 (+1.00%)
NIO   32.23 (-17.95%)
AMD   75.67 (-2.68%)
T   29.39 (+1.63%)
F   11.82 (-0.92%)
ACB   8.98 (-8.55%)
DIS   185.35 (-1.43%)
BA   216.76 (-3.54%)
NFLX   505.39 (-1.15%)
BAC   36.34 (-0.44%)
Log in
OTCMKTS:BFNH

BioForce Nanosciences Stock Forecast, Price & News

$0.66
0.00 (0.00 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.66
Now: $0.66
$0.66
50-Day Range
$0.25
MA: $0.59
$1.00
52-Week Range
$0.25
Now: $0.66
$2.00
VolumeN/A
Average Volume5,377 shs
Market Capitalization$10.11 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.56
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.
BioForce Nanosciences logo

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BFNH
CUSIPN/A
CIKN/A
Phone757 306 6090
Employees2
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$20,000.00

Profitability

Net Income$-50,000.00
Return on Assets-328,192.44%

Miscellaneous

Market Cap$10.11 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.17 out of 5 stars

Medical Sector

1789th out of 1,969 stocks

Analytical Instruments Industry

28th out of 29 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
$0.66
0.00 (0.00 %)
(As of 03/4/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BFNH News and Ratings via Email

Sign-up to receive the latest news and ratings for BFNH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











BioForce Nanosciences (OTCMKTS:BFNH) Frequently Asked Questions

What stocks does MarketBeat like better than BioForce Nanosciences?

Wall Street analysts have given BioForce Nanosciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BioForce Nanosciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting BioForce Nanosciences?

BioForce Nanosciences saw a decrease in short interest in February. As of February 12th, there was short interest totaling 100 shares, a decrease of 80.0% from the January 28th total of 500 shares. Based on an average daily trading volume, of 4,500 shares, the days-to-cover ratio is presently 0.0 days.
View BioForce Nanosciences' Short Interest
.

Who are BioForce Nanosciences' key executives?

BioForce Nanosciences' management team includes the following people:
  • Mr. Merle Ferguson, Chairman, CEO, Treasurer & Pres (Age 74)
  • Mr. Richard Kaiser, CFO, Corp. Sec., Corp. Governance Officer & Director (Age 55)

Who are some of BioForce Nanosciences' key competitors?

What is BioForce Nanosciences' stock symbol?

BioForce Nanosciences trades on the OTCMKTS under the ticker symbol "BFNH."

How do I buy shares of BioForce Nanosciences?

Shares of BFNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioForce Nanosciences' stock price today?

One share of BFNH stock can currently be purchased for approximately $0.66.

How much money does BioForce Nanosciences make?

BioForce Nanosciences has a market capitalization of $10.11 million and generates $20,000.00 in revenue each year.

How many employees does BioForce Nanosciences have?

BioForce Nanosciences employs 2 workers across the globe.

What is BioForce Nanosciences' official website?

The official website for BioForce Nanosciences is www.bioforceeclipse.com.

Where are BioForce Nanosciences' headquarters?

BioForce Nanosciences is headquartered at 2020 GENERAL BOOTH BLVD UNIT 230, VIRGINIA BEACH VA, 23454.

How can I contact BioForce Nanosciences?

BioForce Nanosciences' mailing address is 2020 GENERAL BOOTH BLVD UNIT 230, VIRGINIA BEACH VA, 23454. The company can be reached via phone at 757 306 6090 or via email at [email protected]


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.